Review Article

Management of Metastatic Spinal Cord Compression

Authors: Quaovi Sodji, MD, PhD, Joseph Kaminski, MD, Christopher Willey, MD, PhD, Nathan Kim, MD, PhD, Waleed Mourad, MD, PhD, John Vender, MD, Byron Dasher, MD

Abstract

Cancer metastasis is a key event in tumor progression associated not only with mortality but also significant morbidity. Metastatic disease can promote end-organ dysfunction and even failure through mass effect compression of various vital organs including the spinal cord. In such cases, prompt medical attention is needed to restore neurological function, relieve pain, and prevent permanent damage. The three therapeutic approaches to managing metastatic spinal cord compression include corticosteroids, surgery, and radiation therapy. Although each may improve patients’ symptoms, their combination has yielded the best outcome. In cancer patients with clinical suspicion of spinal cord compression, dexamethasone should be initiated followed by surgical decompression, when possible, and radiation. The latter becomes the preferred treatment in patients with inoperable disease.

 

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Boriani S, Biagini R, De Iure F, et al. Primary bone tumors of the spine: a survey of the evaluation and treatment at the Istituto Ortopedico Rizzoli. Orthopedics 1995;18:993-1000.
 
2. Loblaw DA, Laperriere NJ, Mackillop WJ. A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol) 2003;15:211-217.
 
3. Helweg-Larsen S, Sø PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 2000;46:1163-1169.
 
4. Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol 2005;6:15-24.
 
5. Talcott JA, Stomper PC, Drislane FW, et al. Assessing suspected spinal cord compression: a multidisciplinary outcomes analysis of 342 episodes. Support Care Cancer 1999;7:31-38.
 
6. Loblaw DA, Laperriere N, Mackillop WJ. Who should be screened for malignant spinal cord compression? Defining a high-risk population. Clin Invest Med 2000;23: Abstract 142.
 
7. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-572.
 
8. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
 
9. Hrabalek L. Intramedullary spinal cord metastases: review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010;154:117-122.
 
10. Pigott KH, Baddeley H, Maher EJ. Pattern of disease in spinal cord compression on MRI scan and implications for treatment. Clin Oncol (R Coll Radiol) 1994;6:7-10.
 
11. Abrahm JL. Assessment and treatment of patients with malignant spinal cord compression. J Support Oncol 2004;2:377-388., 391.
 
12. Siegal T. Spinal cord compression: from laboratory to clinic. Eur J Cancer 1995;31A:1748-1753.
 
13. Dumont RJ, Okonkwo DO, Verma S, et al. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001;24:254-264.
 
14. Kato A, Ushio Y, Hayakawa T, et al. Circulatory disturbance of the spinal cord with epidural neoplasm in rats. J Neurosurg 1985;63:260-265.
 
15. Georgy BA. Metastatic spinal lesions: state-of-the-art treatment options and future trends. AJNR Am J Neuroradiol 2008;29:1605-1611.
 
16. Bach F, Larsen BH, Rohde K, et al. Metastatic spinal cord compression. Occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir (Wien) 1990;107:37-43.
 
17. Helweg-Larsen S, Sørensen PS. Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer 1994;30A:396-398.
 
18. Levack P, Graham J, Collie D, et al. Don’t wait for a sensory level-listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Clin Oncol (R Coll Radiol) 2002;14:472-480.
 
19. Orendácová J, Cízková D, Kafka J, et al.. Cauda equina syndrome. Prog Neurobiol 2001;64:613-637.
 
20. Fraser S, Roberts L, Murphy E. Cauda equina syndrome: a literature review of its definition and clinical presentation. Arch Phys Med Rehabil 2009;90:1964-1968.
 
21. Schiff D, O’ BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 1997;49:452-456.
 
22. Li KC, Poon PY. Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae. Magn Reson Imaging 1988;6:547-556.
 
23. Moulopoulos LA, Yoshimitsu K, Johnston DA, et al. MR prediction of benign and malignant vertebral compression fractures. J Magn Reson Imaging 1996;6:667-674.
 
24. Buga S, Sarria JE. The management of pain in metastatic bone disease. Cancer Control 2012;9:154-166.
 
25. Maranzano E, Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. Int J Radiat Oncol Biol Phys 1995;32:959-967.
 
26. Greenberg HS, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 1980;8:361-366.
 
27. Vecht CJ, Haaxma-Reiche H, van Putten WL, et al. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-1257.
 
28. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976) 2010;35:E1221-E1229.
 
29. Siegal T, Siegal T. Surgical decompression of anterior and posterior malignant epidural tumors compressing the spinal cord: a prospective study. Neurosurgery 1985;17:424-432.
 
30. Sundaresan N, Sachdev VP, Holland JF, et al. Surgical treatment of spinal cord compression from epidural metastasis. J Clin Oncol 1995;13:2330-2335.
 
31. Witham TF, Khavkin YA, Gallia GL, et al. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol 2006;2:87-94.
 
32. Findlay GF. Adverse effects of the management of malignant spinal cord compression. J Neurol Neurosurg Psychiatry 1984;47:761-768.
 
33. Harris JK, Sutcliffe JC, Robinson NE. The role of emergency surgery in malignant spinal extradural compression: assessment of functional outcome. Br J Neurosurg 1996;10:27-33.
 
34. Kassamali RH, Ganeshan A, Hoey ET, et al. Pain management in spinal metastases: the role of percutaneous vertebral augmentation. Ann Oncol 2011;22:782-786.
 
35. Itagaki MW, Talenfeld AD, Kwan SW, et al. Percutaneous vertebroplasty and kyphoplasty for pathologic vertebral fractures in the Medicare population: safer and less expensive than open surgery. J Vasc Interv Radiol 2012;23:1423-1429.
 
36. Schmidt R, Wenz F, Reis T, et al. Kyphoplasty and intra-operative radiotherapy, combination of kyphoplasty and intra-operative radiation for spinal metastases: technical feasibility of a novel approach. Int Orthop 2012;36:1255-1260.
 
37. Bhatt AD, Schuler JC, Boakye M, et al. Current and emerging concepts in non- invasive and minimally invasive management of spine metastasis. Cancer Treat Rev 2013;39:142-152.
 
38. Gangi A, Guth S, Imbert JP, et al. Percutaneous vertebroplasty: indications, technique, and results. Radiographics 2003;23:e10.
 
39. Loblaw DA, Perry J, Chambers A, et al. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative’ Neuro-Oncology Disease Site Group. J Clin Oncol 2005;23:2028-2037.
 
40. Maranzano E, Trippa F, Casale M, et al. 8 Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiother Oncol 2009;93:174-179.
 
41. Rades D, Lange M, Veninga T, et al. Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2011;79:524-530.
 
42. Zagars GK, Ballo MT. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2003;56:473-481.
 
43. DeLaney TF, Liebsch NJ, Pedlow FX, et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 2009;74:732-739.
 
44. Schultheiss TE. The radiation dose-response of the human spinal cord. Int J Radiat Oncol Biol Phys 2008;71:1455-1459.
 
45. Milker-Zabel S, Zabel A, Thilmann C, et al. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:162-167.
 
46. Isacsson U, Hagberg H, Johansson KA, et al. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 1997;45:63-70.
 
47. Liu H, Chang JY. Proton therapy in clinical practice. Chin J Cancer 2011;30:315-326.
 
48. Kirkpatrick JP, Kelsey CR, Palta M, et al. Stereotactic body radiotherapy: a critical review for nonradiation oncologists. Cancer 2014;120:942-954.
 
49. Janssen S, Glanzmann C, Lang S, et al. Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacy. Radiat Oncol 2014;9:165.
 
50. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005;8:89-91.
 
51. Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007;25:947-952.
 
52. Garg AK, Wang XS, Shiu AS, et al. Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: the University of Texas MD Anderson Cancer Center experience. Cancer 2011;117:3509-3516.
 
53. Rogers CL, Theodore N, Dickman CA, et al. Surgery and permanent 125I seed paraspinal brachytherapy for malignant tumors with spinal cord compression. Int J Radiat Oncol Biol Phys 2002;54:505-513.
 
54. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003;56:83-88.
 
55. Maranzano E, Bellavita R, Floridi P, et al. Radiation-induced myelopathy in long-term surviving metastatic spinal cord compression patients after hypofractionated radiotherapy: a clinical and magnetic resonance imaging analysis. Radiother Oncol 2001;60:281-288.
 
56. Sørensen S, Helweg-Larsen S, Mouridsen H, et al. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1994;30A:22-27.
 
57. Ghogawala Z, Mansfield FL, Borges LF. Spinal radiation before surgical decompression adversely affects outcomes of surgery for symptomatic metastatic spinal cord compression. Spine (Phila Pa 1976) 2001;26:818-824.
 
58. Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-648.
 
59. Tokuhashi Y, Matsuzaki H, Toriyama S, et al. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 1990;15:1110-1113.
 
60. Tokuhashi Y, Uei H, Oshima M, et al. Scoring system for prediction of metastatic spine tumor prognosis. World J Orthop 2014;5:262-271.
 
61. L'esperance S, Vincent F, Gaudreault M, et al. Treatment of metastatic spinal cord compression: CEPO review and clinical recommendations. Curr Oncol 2012;19:e478-e490.
 
62. Laufer I, Rubin DG, Lis E, et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 2013;18:744-751.
 
63. Bilsky MH, Laufer I, Fourney DR, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine 2010;13:324-328.
 
64. Rades D, Conde-Moreno AJ, Cacicedo J, et al. Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma. Radiol Oncol 2016;50:337-340.
 
65. Rades D, Conde-Moreno AJ, Cacicedo J, et al. Radiation therapy alone provides excellent outcomes for spinal cord compression from vertebral lymphoma. Anticancer Res 2016;36:3081-3083.
 
66. Rades D, Heidenreich F, Karstens JH. Final results of a prospective study of the prognostic value of the time to develop motor deficits before irradiation in metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 2002;53:975-979.
 
67. Rades D, Fehlauer F, Schulte R, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006;24:3388-3393.
 
68. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30:2186-2191.
 
69. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001;26:298-306.
 
70. Aoude A, Amiot LP. A comparison of the modified Tokuhashi and Tomita scores in determining prognosis for patients afflicted with spinal metastasis. Can J Surg 2014;57:188-193.
 
71. Borenstein SH, Gerstle T, Malkin D, et al. The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma. J Pediatr Surg 2000;35:973-976.